NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 760 filers reported holding NOVARTIS A G in Q2 2013. The put-call ratio across all filers is 0.60 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,270,255 | +89.0% | 12,588 | +72.3% | 0.23% | +80.8% |
| Q1 2023 | $671,968 | -27.7% | 7,304 | -25.6% | 0.12% | -56.1% |
| Q4 2019 | $929,000 | +108.8% | 9,814 | +78.3% | 0.28% | -23.8% |
| Q1 2018 | $445,000 | -28.3% | 5,505 | -12.6% | 0.37% | -4.3% |
| Q1 2015 | $621,000 | -87.8% | 6,300 | -91.2% | 0.39% | -60.2% |
| Q2 2013 | $5,085,000 | – | 71,914 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |